How The Novavax (NVAX) Story Is Shifting Toward Licensing Income And COVID Recalibration [Yahoo! Finance]
Novavax, Inc. (NVAX)
Last novavax, inc. earnings: 3/11 04:17 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.novavax.com/investor-relations
Company Research
Source: Yahoo! Finance
Novavax's modeled fair value has been reset to US$13.78 from US$13.11, a small move that still matters if you are tracking how assumptions are shifting. Behind that change, recent Street research blends cautious optimism with ongoing concern, as analysts rework their views on the COVID franchise, expense profile, and the contribution from licensing income. Read on to see what is driving these revisions and how you can keep up with the evolving story around Novavax. Stay updated as the Fair Value for Novavax shifts by adding it to your watchlist or portfolio . Alternatively, explore our Community to discover new perspectives on Novavax. What Wall Street Has Been Saying ?? Bullish Takeaways TD Cowen lifted its Novavax target to US$8 from US$7, reflecting updated estimates that factor in Sanofi reported Nuvaxovid sales of €9m and the new Pfizer license agreement, including a US$30m upfront payment and high mid single digit royalties on Pfizer products using Matrix M. BofA also
Show less
Read more
Impact Snapshot
Event Time:
NVAX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVAX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVAX alerts
High impacting Novavax, Inc. news events
Weekly update
A roundup of the hottest topics
NVAX
News
- Is Trending Stock Novavax, Inc. (NVAX) a Buy Now? [Yahoo! Finance]Yahoo! Finance
- Novavax, Inc. (NVAX) Presents at TD Cowen 46th Annual Health Care Conference Transcript [Seeking Alpha]Seeking Alpha
- Novavax Profit And Partnership Pivot Reframe Risk And Valuation Story [Yahoo! Finance]Yahoo! Finance
- Why Novavax (NVAX) Shares Are Falling Today [Yahoo! Finance]Yahoo! Finance
- Novavax (NVAX) had its price target raised by HC Wainwright from $11.00 to $16.00. They now have a "buy" rating on the stock.MarketBeat
NVAX
Earnings
- 2/26/26 - Beat
NVAX
Sec Filings
- 3/5/26 - Form 4
- 3/5/26 - Form 4
- 3/5/26 - Form 4
- NVAX's page on the SEC website